How many clinical trials are tracked of ipragliflozin?

3 trials are tracked, 3 with published results.

Mode

All Oncology Infectious Disease Neurology Psychiatry Cardiology Diabetes & Endocrinology Pediatrics Allergy & Immunology Rheumatology Primary Care & Family Medicine Gastroenterology Nutrition & Obesity Medicine Orthopedics & Sports Medicine OB/GYN & Women's Health Radiology & Imaging Genetics & Precision Medicine Anesthesiology & Pain Medicine Pulmonology & Critical Care Nephrology Emergency Medicine Physical Medicine & Rehab Urology Ophthalmology Hematology Dermatology Geriatrics & Aging ENT (Otolaryngology) Palliative Care

Research

Clinical Trials Drug Pipeline Weekly Digests

Reference

Conditions Medications

Community

Questions

Text Size

ipragliflozin

1 published article · Updated continuously

Clinical Trial Landscape

Clinical Trials of ipragliflozin

3 trials tracked of ipragliflozin: 3 in phase 3 or 4 and 3 with published results. The most-cited published study has 8 citations.

3Trials tracked

3Phase 3 & 4

0Recruiting

3With published results

Phase distribution

Phase 3 3

Phase 3 Double-blind Ipragliflozin Add-on Study in Japanese Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Sitagliptin (MK-0431J-843) Completed · 8 cited
Phase 3 Ipragliflozin Add-on Long-term Study in Japanese Participants With Type 2 Diabetes Mellitus on Sitagliptin (MK-0431J-849) Completed · 8 cited
Phase 3 Double-blind Sitagliptin Add-on Study in Japanese Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Ipragliflozin (MK-0431J-842) Completed · 4 cited

Showing the 3 most-cited and recently-updated of 3 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.